Table 2.
Annotated upstream kinases potentially responsible for the altered phosphorylation levels upon GD1a treatment of OLGs
Condition | Kinases up | Peptides | Kinases down | Peptides |
---|---|---|---|---|
0 vs 10 min | Not known | |||
0 vs 20 min | PKA | 4 | CDK2/CDK7 | 1 |
PKG/cGK | 2 | GSK3, RSK, CAM-KII, CDK3, SGK, DYRK3 | 1 | |
P70S6K | 2 | |||
RSK group | 2 | |||
PKB group | 2 | |||
PKC-α | 1 | |||
PIM1 | 1 | |||
CAM-KII | 1 | |||
AMPK | 1 | |||
0 vs 16 h | PKB group | 2 | ||
ATM | 1 | |||
CDK2/CDK7 | 1 | |||
PKA group | 1 | |||
20 min vs 16 h | ATM | 1 | PKA group | 2 |
PKA group, PKG/cGK group | 1 | PKB group | 3 | |
GSK3 group, RSK group, CDK3, CAM-KII group, CAM-KIV, DYRK3, MAPKAP2, SGK group | 1 | PKC group | 1 | |
RSK group | 1 | |||
CDK2/CDK7 | 1 | |||
PIM1 | 1 | |||
Aurora A/B | 1 |